IGF-1 LR 3 1 mg

Extended-Action IGF-1 Analog

In plain terms: This is an engineered version of a natural growth factor, modified to stay

active longer than the body’s own version. Researchers use it as a tool to study cell

growth and protein synthesis pathways in isolation.

Compound classification: IGF-1 LR3 is a synthetic analog of Insulin-like Growth Factor

1, modified to reduce IGF-binding protein affinity.

Studied mechanism: Research has examined IGF-1 LR3 receptor binding and

downstream signaling associated with cellular proliferation and protein synthesis in

research models.

Research findings: Preclinical and in-vitro research has documented extended receptor

activation and myoblast proliferation markers relative to native IGF-1, supporting its use

as a research tool for isolating growth-signaling pathways.

Effects reported in research literature:

Hypoglycemia (in research models)

Injection site reactions (in study subjects)

Fatigue

Research status: Long-term safety and efficacy data for this compound remain under

investigation.

Research Use Only: This compound is intended for laboratory research use only. It is

not a drug, dietary supplement, or consumer product, and is not for human or animal

consumption. Statements have not been evaluated by the FDA and are not intended to

diagnose, treat, cure, or prevent any disease.